Maximizing the benefits of using biosimilars in Egypt

BACKGROUND: Biosimilars constitute a pathway for sustainable financing of healthcare systems in the era of expensive biologics. However, such a pathway is not free of challenges. Since the biosimilars market is expanding in Egypt, there is an urgent need for a policy framework to optimize their use...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasseeh, Ahmad Nader, Elezbawy, Baher, El-Fass, Kareem Ahmed, GamaI, Mary, Seyam, Ahmed, Hayek, Noha, Abdel Rahman, Nagwan, Abdelhamid, Sohir, Fasseeh, Nader, Saad, Amr Shafik, Elagamy, Ahmed, Mahmoud, Akram, Sedrak, Amal Samir, Elshazly, Khaled, Eldebeiky, Mariam, Talaat, Monica, Mohamed, Noura Maher, Abdelaziz, Rania Ahmed, Refaat, Remonda, Akeel, Shaimaa, Abaza, Sherif, Kaló, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291771/
https://www.ncbi.nlm.nih.gov/pubmed/37365620
http://dx.doi.org/10.1186/s40545-023-00581-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291771/
https://www.ncbi.nlm.nih.gov/pubmed/37365620
http://dx.doi.org/10.1186/s40545-023-00581-w

Ejemplares similares